FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights

iza-bren egfrxher3 bispecific press release

Enrique Soto: New ASCO Global Guideline on Geriatric Assessment

Enrique Soto

Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy

Katy Rezvani

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM

Zihai Li

Calculators

Body Mass Index (BMI)

Cockcroft-Gault Creatinine Clearance Calculator

BSA Calculator – Body Surface Area

Carboplatin Dose Calculator: Calvert Formula

Child-Pugh Score Calculator

ECOG Score Calculator

Cockcroft-Gault Creatinine Clearance Calculator

The Cockcroft-Gault Creatinine Clearance (CrCl) Calculator is a widely used tool to estimate a patient’s kidney function. It uses a formula incorporating a patient’s age, weight, sex, and serum creatinine level to calculate an estimated creatinine clearance in mL/min. This estimate is crucial for healthcare professionals, particularly for adjusting drug dosages in patients with impaired kidney function, ensuring medication safety and efficacy. While newer equations exist, Cockcroft-Gault remains commonly referenced due to its historical use in drug development studies.

UNIT

SEX